Mahmoud Azza A K, Hassan Alharith A A, Dobó Dorina Gabriella, Ludasi Krisztina, Janovák László, Regdon Géza, Csóka Ildikó, Kristó Katalin
Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös u. 6., H-6720 Szeged, Hungary.
Department of Physical Chemistry and Materials Science, University of Szeged, Rerrich B. sq. 1, H-6720 Szeged, Hungary.
Pharmaceutics. 2024 Jun 22;16(7):848. doi: 10.3390/pharmaceutics16070848.
The preparation of pellets using a high-shear granulator in a rapid single-step is considered a good economic alternative to the extrusion spheronization process. As process parameters and material attributes greatly affect pellet qualities, successful process optimization plays a vital role in producing pellet dosage forms with the required critical quality attributes. This study was aimed at the development and optimization of the pelletization technique with the Pro-CepT granulator. According to the quality by design (QbD) and screening design results, chopper speed, the volume of the granulating liquid, binder amount, and impeller speed were selected as the highest risk variables for a two-level full factorial design and central composite design, which were applied to the formula of microcrystalline cellulose, mannitol, and with a binding aqueous polyvinylpyrrolidone solution. The design space was estimated based on physical response results, including the total yield of the required size, hardness, and aspect ratio. The optimized point was tested with two different types of active ingredients. Amlodipine and hydrochlorothiazide were selected as model drugs and were loaded into an optimized formulation. The kinetics of the release of the active agent was examined and found that the results show a correlation with the electrokinetic potential because amlodipine besylate can be adsorbed on the surface of the MCC, while hydrochlorothiazide less so; therefore, in this case, the release of the active agent increases. The research results revealed no significant differences between plain and model drug pellets, except for hydrochlorothiazide yield percent, in addition to acceptable content uniformity and dissolution enhancement.
使用高剪切制粒机快速一步制备微丸被认为是挤出滚圆法的一种良好经济替代方法。由于工艺参数和物料属性对微丸质量有很大影响,成功的工艺优化对于生产具有所需关键质量属性的微丸剂型起着至关重要的作用。本研究旨在开发和优化使用Pro-CepT制粒机的制粒技术。根据质量源于设计(QbD)和筛选设计结果,选择切碎机速度、制粒液体积、黏合剂用量和叶轮速度作为两级全因子设计和中心复合设计的最高风险变量,将其应用于微晶纤维素、甘露醇配方以及黏合性聚乙烯吡咯烷酮水溶液。基于物理响应结果估计设计空间,包括所需尺寸的总收率、硬度和纵横比。用两种不同类型的活性成分对优化点进行测试。选择氨氯地平和氢氯噻嗪作为模型药物,并将其载入优化配方中。考察了活性剂的释放动力学,发现结果显示与动电位相关,因为苯磺酸氨氯地平可吸附在微晶纤维素表面,而氢氯噻嗪则较少吸附;因此,在这种情况下,活性剂的释放增加。研究结果表明,除氢氯噻嗪收率百分比外,普通微丸和模型药物微丸之间无显著差异,此外含量均匀度和溶出度提高也在可接受范围内。